Multivariate analysis of cholesterol distribution for monitoring the risk of coronary heart disease.

The screening of people for potential coronary heart disease and the monitoring of subjects considered at risk have been performed for some time by measuring total serum cholesterol and its constituent lipoproteins. However, these measurements vary substantially within subjects, making such assessments imprecise. It has been suggested that greater consistency can be achieved by analysing the joint distribution of the individual lipoproteins or of transformed variables derived from them. In this paper we present the results of a laboratory experiment to investigate these ideas with a view to improving current methods of monitoring patients at risk. Nested, random-effects, multivariate analysis of variance and the log-ratio analysis of compositions are used to include information on all three lipoproteins simultaneously, and ratios of generalized variances are used to assess and compare the different response variables. The multivariate approach is seen to be far superior to the usual methods. Recommendations are made for routine monitoring and the practical implications are discussed.

[1]  S. Gidding,et al.  Day-to-day variability of serum cholesterol, triglyceride, and high-density lipoprotein cholesterol levels. Impact on the assessment of risk according to the National Cholesterol Education Program guidelines. , 1990, Archives of Internal Medicine.

[2]  R. Macwalter,et al.  Biological variability of 26 clinical chemistry analytes in elderly people. , 1989, Clinical chemistry.

[3]  W. Harris,et al.  Variabilities in Serum Lipid Measurements , 1990 .

[4]  A. J. Collins,et al.  Introduction To Multivariate Analysis , 1981 .

[5]  M. C. Jones,et al.  The Statistical Analysis of Compositional Data , 1986 .

[6]  W. Harris,et al.  Variabilities in serum lipid measurements. Do they impede proper diagnosis and treatment of dyslipidemia? , 1990, Archives of internal medicine.

[7]  S. Gidding,et al.  Day-to-day variability of serum cholesterol, triglyceride, and high-density lipoprotein cholesterol levels. Impact on the assessment of risk according to the National Cholesterol Education Program guidelines. , 1990, Archives of internal medicine.

[8]  E. Schaefer,et al.  Lipoprotein cholesterol concentrations in the plasma of human subjects as measured in the fed and fasted states. , 1988, Clinical chemistry.

[9]  A. Dempster Elements of Continuous Multivariate Analysis , 1969 .

[10]  M C Hjortland,et al.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. , 1977, The American journal of medicine.

[11]  J. Hupp Lowering Blood Cholesterol to Prevent Heart Disease , 1985, International Journal of Technology Assessment in Health Care.

[12]  S B Hulley,et al.  HDL Cholesterol and Other Lipids in Coronary Heart Disease: The Cooperative Lipoprotein Phenotyping Study , 1977, Circulation.

[13]  E. K. Harris,et al.  DISTINGUISHING PHYSIOLOGIC VARIATION FROM ANALYTIC VARIATION. , 1970, Journal of chronic diseases.

[14]  C G Fraser,et al.  Generation and application of data on biological variation in clinical chemistry. , 1989, Critical reviews in clinical laboratory sciences.

[15]  S. S. Wilks CERTAIN GENERALIZATIONS IN THE ANALYSIS OF VARIANCE , 1932 .